NTRB
NASDAQ · Pharmaceuticals
Nutriband Inc
$5.52
-0.56 (-9.21%)
Open$5.96
Previous Close$6.08
Day High$5.97
Day Low$5.28
52W High$9.19
52W Low$2.80
Volume—
Avg Volume24.3K
Market Cap67.71M
P/E Ratio—
EPS$-0.58
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+525.2% upside
Current
$5.52
$5.52
Target
$34.51
$34.51
$26.32
$34.51 avg
$56.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.15M | 2.16M | 21.69M |
| Net Income | -8,671,912 | -7,858,947 | 2.61M |
| Profit Margin | -404.1% | -383.9% | 12.0% |
| EBITDA | -8,560,293 | -8,188,780 | 4.63M |
| Free Cash Flow | — | — | 2.95M |
| Rev Growth | -0.7% | -0.7% | +19.5% |
| Debt/Equity | 0.02 | 0.02 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |